Guidelines for Detection and Management of Fetal Growth Restriction (FGR)

1. Primary Screening Triggers

Fundal‑height discrepancy ≥ 3 cm below gestational age (McDonald rule) should prompt immediate obstetric ultrasound. ACOG recommends this threshold for early detection of possible FGR. 1
Fundal height below the 10th percentile on customized growth charts warrants an ultrasound evaluation. This criterion helps identify fetuses at risk despite maternal habitus. 2
A change in fundal height of ≤ 5 mm over a 14‑day interval indicates static or slow growth and should trigger ultrasound assessment. Early identification prevents delayed diagnosis. 3
Serial fundal‑height measurements are advised beginning at 24–26 weeks gestation and continued at every prenatal visit. Routine tracking improves sensitivity for growth abnormalities. 2

2. Ultrasound Biometry Thresholds

Estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile defines fetal growth restriction. This percentile cut‑off distinguishes pathologic growth restriction from normal variation. 4
EFW below the 3rd percentile denotes severe FGR and requires intensified surveillance irrespective of Doppler findings. Severe restriction is linked to higher perinatal morbidity. 4
Population‑based growth references (e.g., Hadlock curves) are preferred over customized standards for diagnosing FGR. Standardized curves reduce misclassification. 4

3. Maternal Risk Factors Requiring Enhanced Surveillance

Chronic hypertension or pre‑eclampsia is present in 50–70 % of early‑onset FGR cases and independently predicts adverse outcomes. These conditions merit earlier and more frequent monitoring. 5
A history of prior FGR justifies low‑dose aspirin initiation before 16 weeks gestation for prevention. Aspirin has demonstrated benefit in reducing recurrence. 2
Antiphospholipid syndrome is associated with placental insufficiency and should trigger early Doppler assessment. The syndrome increases risk of growth compromise. 1
Diabetes with vascular complications elevates the risk of placental dysfunction and subsequent FGR. Tight glycemic control and surveillance are advised. 1
Maternal smoking or substance abuse are modifiable risk factors; cessation counseling is essential to mitigate FGR risk. Behavioral interventions improve fetal growth trajectories. 2
Uterine anomalies may impair placental perfusion and should prompt Doppler evaluation beginning at 26–28 weeks. Structural uterine issues can limit fetal nutrient delivery. 1

4. Doppler Assessment Guidelines

Umbilical artery pulsatility index (UA‑PI) > 95th percentile (reduced end‑diastolic flow) confirms placental vascular resistance and pathological FGR. This Doppler finding differentiates true restriction from constitutional smallness. 4
Absent end‑diastolic velocity (AEDV) requires 2–3 times weekly Doppler monitoring due to rapid risk of deterioration. Frequent surveillance allows timely intervention. 4
Reversed end‑diastolic velocity (REDV) mandates hospitalization, administration of antenatal corticosteroids, and consideration of delivery irrespective of gestational age. REDV signals imminent fetal compromise. 4
Maternal risk factors (e.g., hypertension, prior FGR, antiphospholipid syndrome) should trigger umbilical artery Doppler studies starting at 26–28 weeks gestation. Early Doppler helps stratify risk and guide management. 3

5. Oligohydramnios as a Supporting Indicator

Amniotic fluid index < 5 cm or maximum vertical pocket < 2 cm reflects chronic placental insufficiency and should raise suspicion for FGR. Reduced fluid volume often accompanies compromised fetal renal perfusion. 1

6. Early‑Onset FGR (< 32 weeks) Evaluation

Up to 20 % of early‑onset FGR cases are associated with fetal malformations or chromosomal abnormalities; a detailed anatomic survey (CPT 76811) is mandatory. Comprehensive imaging identifies co‑existing anomalies. 4
Chromosomal microarray analysis is recommended for unexplained isolated FGR diagnosed before 32 weeks gestation. Genetic testing can uncover submicroscopic abnormalities. 4
If amniocentesis is performed, PCR testing for cytomegalovirus (CMV) should be offered, whereas routine screening for toxoplasmosis, rubella, or herpes is not indicated. Targeted infectious work‑up focuses on clinically relevant pathogens. 4

7. Outcomes and Common Pitfalls

Approximately 18–22 % of fetuses with EFW/AC < 10th percentile are constitutionally small and have normal perinatal outcomes. Recognition prevents unnecessary intervention. 2
Do not delay umbilical artery Doppler assessment once FGR is suspected; Doppler is essential for distinguishing pathological restriction from constitutional smallness and for determining surveillance intensity. Prompt Doppler informs timely clinical decisions. 4
Avoid reliance on customized growth standards; population‑based references (Hadlock) are recommended for accurate diagnosis of FGR. Standardized charts improve diagnostic consistency. 4

Management of Fundal Height Variability Between 20-36 Weeks

Initial Assessment and Ultrasound Evaluation

The American College of Obstetricians and Gynecologists recommends proceeding immediately to ultrasound evaluation with biometry and umbilical artery Doppler studies when fundal height measurements show variability or discrepancy (>3 cm less than gestational age in weeks, <10th percentile on customized charts, or slow/static growth with <5 mm change over 14 days) 6, 7, 8
Fundal height >3 cm less than gestational age in weeks (McDonald rule threshold) requires immediate ultrasound evaluation 7, 8
Fundal height <10th percentile on customized growth charts necessitates ultrasound evaluation 6, 7
Slow or static growth: change in fundal height <5 mm over 14 days requires ultrasound evaluation 6, 7

Comprehensive Ultrasound Assessment

Estimated fetal weight (EFW) and abdominal circumference (AC) should be assessed to diagnose fetal growth restriction (FGR), defined as EFW <10th percentile 9
Umbilical artery Doppler velocimetry should be used to assess placental function and guide surveillance frequency 7, 9
Amniotic fluid volume assessment using maximum vertical pocket (MVP ≥2 cm normal) or amniotic fluid index should be performed 10
Detailed anatomic survey is recommended if early-onset FGR (<32 weeks) is suspected, since up to 20% of cases have fetal or chromosomal abnormalities 9

Management Algorithm Based on Ultrasound Findings

For confirmed FGR (EFW <10th percentile) with normal umbilical artery Doppler, serial ultrasound every 2 weeks for growth assessment, weekly umbilical artery Doppler monitoring, and weekly cardiotocography (NST) after viability are recommended 7, 9
Delivery at 38-39 weeks gestation is recommended for FGR with normal umbilical artery Doppler 9
For abnormal umbilical artery Doppler (decreased end-diastolic velocity, PI >95th percentile), weekly umbilical artery Doppler evaluation, twice-weekly cardiotocography, and delivery at 37 weeks gestation are recommended 7, 9
For severe FGR (EFW <3rd percentile) with normal Doppler, weekly umbilical artery Doppler, increased surveillance frequency, and delivery at 37 weeks gestation are recommended 9

Special Considerations and Caveats

The American College of Obstetricians and Gynecologists recommends proceeding directly to ultrasound rather than relying on fundal height in women with obesity or increased body mass index, fibroid uterus, abdominal distention, or multiple gestations or non-longitudinal fetal lie 8, 11, 12
Chromosomal microarray analysis (CMA) should be offered when FGR is unexplained and isolated 9
PCR testing for cytomegalovirus (CMV) is recommended if diagnostic testing with amniocentesis is performed 9
Routine screening for toxoplasmosis, rubella, or herpes is not recommended in the absence of other risk factors 9

Fundal Height Assessment in Specific Pregnancy Scenarios

Multiple Gestations

In twin pregnancies, fundal‑height measurements are less reliable because fetal positioning varies; therefore, an ultrasound should be performed instead of relying on tape measurement. 13
A crown‑rump‑length discrepancy of ≥60 % between twins at 11–14 weeks predicts subsequent growth restriction and is associated with a 100 % risk of fetal demise. 13

Polyhydramnios

Excess amniotic fluid that raises fundal height above the expected gestational age is frequently linked to fetal anomalies, maternal diabetes, and twin‑to‑twin transfusion syndrome in monochorionic pregnancies. 13

Fetal Presentation

Breech presentation can modify the measured fundal height compared with a cephalic presentation, potentially leading to inaccurate assessment of fetal growth. 13

Management of Fetal Growth Restriction (FGR) in Pregnancy

Diagnostic Evaluation

Surveillance and Monitoring

Delivery Timing and Indications

Antenatal Therapeutics

Management of Concurrent Infections

Intrapartum Management

Neonatal and Postpartum Care

Long‑Term Follow‑Up

Fetal Biometry and Growth Assessment Guidelines at 29 Weeks Gestation

Estimated Fetal Weight and Measurement Accuracy

The American Journal of Obstetrics & Gynecology reports that the normal estimated fetal weight (EFW) at 29 weeks ranges from approximately 1,200 g to 1,400 g (10th–90th percentile), calculated using regression equations that combine biparietal diameter, head circumference, abdominal circumference, and femur length. 18
Formulas that incorporate three to four fetal biometric indices are significantly more accurate for predicting birthweight (1,000–4,500 g) than formulas using only one or two indices. 18

Definition of Fetal Growth Restriction and Early‑Onset Classification

Fetal growth restriction (FGR) is defined as an EFW or abdominal circumference below the 10th percentile for gestational age, while severe FGR is defined as an EFW below the 3rd percentile. 18
At 29 weeks gestation, any diagnosed growth restriction is classified as early‑onset FGR (diagnosed before 32 weeks), which is typically more severe and associated with placental dysfunction. [19][18]

Amniotic Fluid Assessment

The normal amniotic fluid index (AFI) at 29 weeks should be ≥ 5 cm, and the maximum vertical pocket (MVP) should be ≥ 2 cm. 20

Ultrasound Quality Assurance and Gestational Dating

Implementation of quality‑assurance programs for ultrasound measurements—such as averaging multiple measurements—enhances reliability and accuracy of fetal biometry. 18
Accurate pregnancy dating using first‑trimester crown‑rump length is essential before interpreting 29‑week biometric data; dating errors can lead to misclassification of growth status. 18

Umbilical Artery Doppler Assessment

In pregnancies complicated by early‑onset severe fetal growth restriction (EFW < 3rd percentile), the American College of Radiology recommends performing umbilical artery Doppler studies as the primary test to distinguish pathological placental insufficiency from constitutional smallness and to determine the intensity of surveillance. 21
Interpretation of Doppler results and corresponding management (population: fetuses < 32 weeks with severe FGR):
- Normal Doppler (pulsatility index < 95th percentile): weekly umbilical artery Doppler + weekly non‑stress test after fetal viability; planned delivery at 37 weeks. 21
- Decreased end‑diastolic flow (PI > 95th percentile): weekly Doppler + twice‑weekly non‑stress test; delivery at 37 weeks. 21
- Absent end‑diastolic velocity (AEDV): Doppler 2–3 times per week, administration of antenatal corticosteroids, delivery at 33–34 weeks. 21
- Reversed end‑diastolic velocity (REDV): immediate hospitalization, antenatal corticosteroids, magnesium sulfate for neuroprotection, delivery at 30–32 weeks. 21

Amniotic Fluid Volume Assessment

For the same high‑risk population, an amniotic fluid index < 5 cm or a maximum vertical pocket < 2 cm (oligohydramnios) is identified by the American College of Radiology as a marker of chronic placental insufficiency that worsens perinatal prognosis. 21

Gestational Age Dating Accuracy

When first‑trimester crown‑rump length dating is uncertain, the American College of Radiology advises repeating the evaluation and focusing on growth velocity rather than relying on a single percentile measurement to avoid misclassification of fetal growth restriction. [21][22]